Clinical Trials For Patients With Refractory Angina

Have you been diagnosed with refractory angina and are out of options? Discover innovative research at the Texas Heart Institute. The Stem Cell Center of the Texas Heart Institute at St. Luke’s Episcopal Hospital in Houston, Texas is actively recruiting patients for FDA-approved clinical studies investigating the use of adult stem cells in treating refractory angina.

Patients with coronary artery disease experience angina when the arteries in the heart are narrowed by arteriosclerosis and is unable to allow enough blood to reach the heart muscle. The lack of oxygenated blood feeding the tissues causes chest pain. Symptoms are usually brought on by over eating, physical activity, excitement, anxiety, or just doing nothing at all. Patients who have refractory angina do not experience relief from chest pain when conventional treatments are used such as medication, bypass surgery, and angioplasty. These patients are considered "no-option" patients.

Inclusion Criteria

The Stem Cell Center is actively enrolling patients who:

• are on maximal medical therapy for the symptoms of angina.
• have frequent episodes of angina.
• have a low to normal ejection fraction.
• have exhausted all conventional therapy (i.e., bypass surgery, stenting and angioplasty).

Many factors are considered before enrolling patients into a research study and enrollment varies according to inclusion criteria.

Enrollment Information

If you are a patient who has been diagnosed with refractory angina and wishes to be considered for enrollment in a trial, please call us at 1-866-924-STEM(7836), or complete our secure online Patient Information Form.

For more specific information about this study, please visit the study website: Renewstudy.com

If you are a physician and would like to refer a patient for consideration, please contact a study coordinator at the above number or 832-355-9405.